The VEGF Inhibitor Market has emerged as a pivotal segment within the pharmaceutical industry, focusing on therapies that target Vascular Endothelial Growth Factor (VEGF). VEGF plays a crucial role in angiogenesis, the formation of new blood vessels from pre-existing ones, which is a hallmark of several diseases, especially cancers and eye disorders. Inhibition of VEGF is a strategy employed to...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian